My Medical Gateway Blog

HM Hospitales is one of Spain’s most trusted private healthcare groups, now available directly through My Medical Gateway. With over 20 university-affiliated hospitals across Madrid, Barcelona, Galicia and the Costa del Sol, it delivers more than 100,000 surgeries each year across oncology, cardiology, orthopaedics, fertility and advanced diagnostics. British patients seeking faster treatment without sacrificing clinical standards can now access named specialists, modern facilities and English-speaking coordination – all with clear pricing and no uncertainty. 

When UK patients consider travelling abroad for treatment, reassurance matters more than price. They want to know where they’re going, who is treating them, and whether the hospital group they choose is truly equivalent-or superior-to what they would receive privately in the UK. HM Hospitales, now partnered with My Medical Gateway, comfortably meets that standard.

Founded in 1989, HM Hospitales has grown into one of Spain’s most significant private healthcare networks. It is not a loose association of clinics, but a structured group of university-affiliated hospitals operating across Madrid, Barcelona, Galicia and the Costa del Sol. In Madrid alone, Hospital Universitario HM Sanchinarro and Hospital Universitario HM Montepríncipe serve as flagship centres, both recognised for their clinical excellence and academic roles in training doctors and hosting research programmes. In Catalonia, HM Nou Delfos in Barcelona anchors the regional network, while in Andalusia, HM Málaga and HM Santa Elena in Estepona provide access to high-grade surgical and diagnostic services for the southern coast. In Móstoles, just outside Madrid, HM Puerta del Sur operates as a major hub for surgery, oncology and specialist rehabilitation.

Scale is one of the clearest measures of capability. In 2024, HM Hospitales carried out more than four million consultations and close to 120,000 surgeries, with over 50,000 of those delivered as day-case procedures. That level of activity provides confidence not just in competence but in efficiency: these hospitals are not idle facilities waiting for patients. They are high-throughput medical centres where processes are well-defined, waiting times are short and international patients can be scheduled without prolonged negotiation.

Treatment quality is best assessed through the disciplines in which a hospital group chooses to publicly compete. In oncology, HM’s comprehensive cancer institute – CIOCC (Centro Integral Oncológico Clara Campal) – ranks among Spain’s leading cancer centres. In 2024, CIOCC led 144 oncology clinical trials in Madrid’s private sector, placing second in the region when including public institutions. The radiation oncology department at HM Sanchinarro was ranked the best in Spain in the national Healthcare Reputation Monitor, a survey watched closely by doctors and insurers. These are measurable distinctions, not marketing phrases.

Cardiology is another area where HM Hospitales has achieved formal recognition. Its cardiac rehabilitation units at Montepríncipe and Puerta del Sur have been accredited by the Spanish Society of Cardiology, confirming adherence to structured, audited protocols for post-operative recovery and long-term cardiovascular management. Orthopaedics and spine surgery are managed through high-volume centres at Montepríncipe, Puerta del Sur and Nou Delfos, where minimally invasive techniques and accelerated recovery methods are standard practice. For women’s health and fertility, HM operates comprehensive gynaecology units alongside IVF and ICSI programmes in both Madrid and Barcelona, ensuring continuity of care across diagnostics, surgery and reproductive treatment without reliance on third-party providers.

Behind every clinical programme are names that matter. At CIOCC, Dr Antonio Cubillo serves as Director of Medical Oncology, with an international profile in systemic therapy and clinical trials. In radiation oncology, Dr M. Carmen Rubio leads the department at Sanchinarro and Puerta del Sur and is recognised nationally as one of the foremost specialists in her field. In paediatric oncology research, HM Montepríncipe has, since 2025, hosted Spain’s first early-phase clinical trial unit in the private sector through a collaboration with the global START network, led by Dr Marta Osuna Marco. 

Infrastructure matters just as much as medical leadership. HM hospitals operate with modern equipment across MRI, CT, hybrid surgical theatres and advanced radiotherapy platforms, including SBRT and stereotactic systems. Infection control is taken seriously, as reflected in published quality reports. Length of stay, readmission rates and recovery metrics are disclosed annually – a level of transparency that many UK private hospitals do not provide openly.

A frequent concern for British patients is whether logistics will be complicated. HM Hospitales has been treating international patients for more than a decade and runs a dedicated international services team operating 24 hours a day. English-speaking coordinators handle medical records, consultation scheduling, travel documentation and insurer communication. Remote assessments are carried out before travel to confirm suitability, ensuring that no one boards a plane without clarity on what awaits them. After discharge, follow-up is maintained either online or, where necessary, through reports shared with UK-based GPs or specialists. This is not improvised medical tourism; it is structured healthcare delivered across borders with continuity in mind.

What makes HM Hospitales attractive to UK self-pay patients is not just the price advantage – though procedures such as joint replacements, bariatric surgery, cardiac stenting or dental restoration can often be accessed at 30 to 50 per cent below UK private tariffs. It is the combination of recognised medical leadership, audited performance, established infrastructure and clear communication. Patients are treated not as one-off arrivals but as participants in a coordinated clinical pathway.

Through My Medical Gateway, costs are quoted in full, including surgeon, anaesthetist, hospital stay and immediate post-operative care. This is all part of the MMG Treatment Package. Travel and accommodation support are provided where required, and those who prefer to bring partners or family members are assisted with arrangements.

For British patients weighing their options, the addition of HM Hospitales to the MMG platform removes uncertainty. Instead of scouring the internet for unfamiliar clinics, they have access to a tier-one Spanish hospital group with verifiable credentials, named specialists and an international service structure already proven across thousands of cases.

In short: if you are looking for care that is modern, accountable and accessible without delay, HM Hospitales offers the standard of treatment you expect – delivered faster, clearer and with complete assurance.